PubRank

Günther Steger

Author PubWeight™ 53.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005 28.25
2 Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 2009 13.74
3 Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. Lancet Oncol 2008 2.28
4 Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy. Clin Cancer Res 2008 1.57
5 Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer. Wien Klin Wochenschr 2004 1.45
6 Heterogeneous expression and regulation of CD40 in human hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2003 1.40
7 Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 2003 1.13
8 Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6. J Clin Oncol 2003 1.04
9 Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17). Breast Cancer Res Treat 2007 0.97
10 Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit? Clin Breast Cancer 2009 0.87
11 Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy. Cancer 2003 0.82
12 Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy. Wien Med Wochenschr 2008 0.82
13 Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients. Breast Cancer Res Treat 2007 0.80
14 [The use of erythropoiesis-stimulating proteins in anemic patients with malignant diseases]. Wien Klin Wochenschr 2008 0.75